ACUTE SCHIZOPHRENIA-LIKE PSYCHOTIC DISORDER: A CRITICAL APPRAISAL OF ITS DIAGNOSTIC VALIDITY THROUGH A CASE SERIES.
López-Díaz Á, Lara I, Luis Fernández-González J.
Innov Clin Neurosci. 2018 Feb 1;15(1-2):12-13.
Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM, Englund A, Abi-Dargham A, Lewis DA, Di Forti M, Davies C, Sherif M, McGuire P, D'Souza DC.
Neuropharmacology. 2017 Sep 15;124:89-104. doi: 10.1016/j.neuropharm.2017.06.018. Epub 2017 Jun 17.
Droperidol for psychosis-induced aggression or agitation.
Khokhar MA, Rathbone J.
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD002830. doi: 10.1002/14651858.CD002830.pub3.
Cannabis-associated psychosis: current status of research.
Leweke FM, Gerth CW, Klosterkötter J.
CNS Drugs. 2004;18(13):895-910. doi: 10.2165/00023210-200418130-00005.
'As required' medication regimens for seriously mentally ill people in hospital.
Douglas-Hall P, Whicher EV.
Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD003441. doi: 10.1002/14651858.CD003441.pub3.
Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies.
Barichello T, Simoes LR, Quevedo J, Zhang XY.
Curr Top Behav Neurosci. 2020;44:161-205. doi: 10.1007/7854_2018_81.
Family study of acute and transient psychotic disorders: comparison with schizophrenia.
Das SK, Malhotra S, Basu D.
Soc Psychiatry Psychiatr Epidemiol. 1999 Jun;34(6):328-32. doi: 10.1007/s001270050152.
Lack of improvement at week 2 predicts later antipsychotic non-response in people with acute exacerbations of schizophrenia or schizophrenia-like psychosis.
Kishi T.
Evid Based Ment Health. 2016 May;19(2):61. doi: 10.1136/eb-2015-102180. Epub 2016 Mar 3.
Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
Sato M, Numachi Y, Hamamura T.
Schizophr Bull. 1992;18(1):115-22. doi: 10.1093/schbul/18.1.115.
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.
Zamberletti E, Viganò D, Guidali C, Rubino T, Parolaro D.
Int J Neuropsychopharmacol. 2012 Mar;15(2):267-80. doi: 10.1017/S1461145710001185. Epub 2010 Oct 6.
